SLAMF7 and plasma cell myeloma: Taken together, these mouse studies demonstrate that NK cells are key effectors in mediating the biological anti-myeloma effects of Elo through ADCC and direct engagement of SLAMF7, but significant contributions are likely also derived from ADCP by TAMs, as well as supporting adaptive immune responses involving cytotoxic T cells, at least in these mouse models.